SI3062811T1 - Posegi na podlagi angiopoietina za zdravljenje cerebralne malarije - Google Patents

Posegi na podlagi angiopoietina za zdravljenje cerebralne malarije

Info

Publication number: SI3062811T1
Authority: SI; Slovenia
Prior art keywords: angiopoietin; cerebral malaria; treating cerebral; based interventions; interventions
Prior art date: 2013-11-01

Application number

SI201431185T

Other languages

English (en)

Inventor

Ngambo Lisa Arleen Purcell

Sarah J. Higgins

Kevin C. Kain

Original Assignee

Regeneron Pharmaceuticals, Inc.

University Health Network (Uhn)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-11-01

Filing date

2014-10-31

Publication date

2020-07-31

2014-10-31 Application filed by Regeneron Pharmaceuticals, Inc., University Health Network (Uhn) filed Critical Regeneron Pharmaceuticals, Inc.

2020-07-31 Publication of SI3062811T1 publication Critical patent/SI3062811T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Vascular Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Virology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)

SI201431185T 2013-11-01 2014-10-31 Posegi na podlagi angiopoietina za zdravljenje cerebralne malarije SI3062811T1 (sl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201361898539P	2013-11-01	2013-11-01
US201462040514P	2014-08-22	2014-08-22
PCT/US2014/063347 WO2015066426A2 (en)	2013-11-01	2014-10-31	Angiopoietin-based interventions for treating cerebral malaria
EP14800207.4A EP3062811B1 (en)	2013-11-01	2014-10-31	Angiopoietin-based interventions for treating cerebral malaria

Publications (1)

Publication Number	Publication Date
SI3062811T1 true SI3062811T1 (sl)	2020-07-31

Family

ID=51932597

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI201431185T SI3062811T1 (sl)	2013-11-01	2014-10-31	Posegi na podlagi angiopoietina za zdravljenje cerebralne malarije

Country Status (20)

Country	Link
US (4)	US9592271B2 (sl)
EP (1)	EP3062811B1 (sl)
JP (1)	JP2016537416A (sl)
KR (1)	KR20160099085A (sl)
CN (1)	CN105873599A (sl)
AU (1)	AU2014342162B2 (sl)
CA (1)	CA2928852A1 (sl)
CY (1)	CY1121710T1 (sl)
DK (1)	DK3062811T3 (sl)
ES (1)	ES2727532T3 (sl)
HR (1)	HRP20191070T1 (sl)
HU (1)	HUE044660T2 (sl)
LT (1)	LT3062811T (sl)
MX (1)	MX377089B (sl)
PL (1)	PL3062811T3 (sl)
PT (1)	PT3062811T (sl)
RS (1)	RS59000B1 (sl)
SI (1)	SI3062811T1 (sl)
SM (1)	SMT201900295T1 (sl)
WO (1)	WO2015066426A2 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3252079B8 (en)	2006-04-07	2020-09-09	Aerpio Therapeutics LLC	Antibodies that bind human protein tyrosine phosphatase beta (hptp-beta) and uses thereof
US7622593B2 (en)	2006-06-27	2009-11-24	The Procter & Gamble Company	Human protein tyrosine phosphatase inhibitors and methods of use
PL2451279T3 (pl)	2009-07-06	2019-09-30	Aerpio Therapeutics, Inc.	Pochodne benzosulfonamidowe, ich kompozycje i ich zastosowanie w zapobieganiu przerzutom komórek nowotworowych
AU2012323856B2 (en)	2011-10-13	2017-05-25	EyePoint Pharmaceuticals, Inc.	Methods for treating Vascular Leak Syndrome and cancer
US20150050277A1 (en)	2013-03-15	2015-02-19	Aerpio Therapeutics Inc.	Compositions and methods for treating ocular diseases
DK3062811T3 (da)	2013-11-01	2019-05-13	Regeneron Pharma	Angiopoietin-baserede interventioner til behandling af cerebral malaria
US9994560B2 (en)	2014-03-14	2018-06-12	Aerpio Therapeutics, Inc.	HPTP-β inhibitors
CN113713101B (zh)	2015-09-23	2023-07-28	视点制药公司	用tie-2的激活剂治疗眼内压的方法
US10588940B2 (en) *	2015-11-06	2020-03-17	Regeneron Pharmaceuticals, Inc.	Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders
CA3116196A1 (en) *	2018-10-29	2020-05-07	Ottawa Hospital Research Institute	Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof
US12109253B2 (en)	2019-01-30	2024-10-08	Agency For Science, Technology And Research	Use of IGFBP7 for treating malaria
WO2020223209A1 (en)	2019-04-29	2020-11-05	Aerpio Pharmaceuticals, Inc.	Tie-2 activators targeting the schlemm's canal
CN110687289B (zh) *	2019-10-17	2023-04-18	中国人民解放军陆军军医大学	Fgl2蛋白作为疟疾感染标志物的应用
EP4110367A4 (en) *	2020-02-28	2024-05-01	Northwestern University	METHOD FOR INCREASING THE CHAMBER OF WATER OUTFLOW AND REDUCE THE EXTERNAL PRESSURE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1025193A (en)	1911-03-01	1912-05-07	Oliver Jefferson Kennedy	Foldable holder for writing-pads.
PL199645B1 (pl)	1998-12-23	2008-10-31	Regeneron Pharma	Kwas nukleinowy, polipeptyd fuzyjny, kompozycja, wektor, wektor ekspresyjny, układ gospodarz wektor, sposób wytwarzania polipeptydu fuzyjnego, kwas nukleinowy i sposób wytwarzania polipeptydu fuzyjnego
US7691365B2 (en)	2004-09-28	2010-04-06	Aprogen, Inc.	Methods of using chimeric coiled coil molecule to treat ischemic disease
US20070154482A1 (en)	2005-09-12	2007-07-05	Beth Israel Deaconess Medical Center	Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
JO3182B1 (ar) *	2009-07-29	2018-03-08	Regeneron Pharma	مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
US20120189635A1 (en)	2009-07-29	2012-07-26	Regeneron Pharmaceuticals, Inc.	Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)
WO2011093851A1 (en)	2010-01-26	2011-08-04	Scott And White Memorial Hospital And Scott, Sherwood, And Brindley Foundation	Method for treatment of vascular hyperpermeability
AU2012299195B9 (en)	2011-08-19	2018-05-10	Regeneron Pharmaceuticals, Inc	Anti-Tie2 antibodies uses thereof
DK3062811T3 (da)	2013-11-01	2019-05-13	Regeneron Pharma	Angiopoietin-baserede interventioner til behandling af cerebral malaria

2014
- 2014-10-31 DK DK14800207.4T patent/DK3062811T3/da active
- 2014-10-31 SI SI201431185T patent/SI3062811T1/sl unknown
- 2014-10-31 KR KR1020167014463A patent/KR20160099085A/ko not_active Withdrawn
- 2014-10-31 PT PT14800207T patent/PT3062811T/pt unknown
- 2014-10-31 CA CA2928852A patent/CA2928852A1/en not_active Abandoned
- 2014-10-31 HR HRP20191070TT patent/HRP20191070T1/hr unknown
- 2014-10-31 CN CN201480058778.6A patent/CN105873599A/zh active Pending
- 2014-10-31 ES ES14800207T patent/ES2727532T3/es active Active
- 2014-10-31 RS RS20190841A patent/RS59000B1/sr unknown
- 2014-10-31 HU HUE14800207 patent/HUE044660T2/hu unknown
- 2014-10-31 LT LTEP14800207.4T patent/LT3062811T/lt unknown
- 2014-10-31 EP EP14800207.4A patent/EP3062811B1/en active Active
- 2014-10-31 US US14/529,677 patent/US9592271B2/en not_active Expired - Fee Related
- 2014-10-31 MX MX2016005446A patent/MX377089B/es active IP Right Grant
- 2014-10-31 AU AU2014342162A patent/AU2014342162B2/en not_active Ceased
- 2014-10-31 WO PCT/US2014/063347 patent/WO2015066426A2/en not_active Ceased
- 2014-10-31 JP JP2016552251A patent/JP2016537416A/ja active Pending
- 2014-10-31 SM SM20190295T patent/SMT201900295T1/it unknown
- 2014-10-31 PL PL14800207T patent/PL3062811T3/pl unknown
2017
- 2017-01-25 US US15/414,925 patent/US9968653B2/en not_active Expired - Fee Related
2018
- 2018-04-10 US US15/949,472 patent/US10251938B2/en not_active Expired - Fee Related
2019
- 2019-02-21 US US16/282,199 patent/US10525106B2/en not_active Expired - Fee Related
- 2019-05-06 CY CY20191100475T patent/CY1121710T1/el unknown

Also Published As

Publication number	Publication date
LT3062811T (lt)	2019-05-10
WO2015066426A2 (en)	2015-05-07
CY1121710T1 (el)	2020-07-31
WO2015066426A3 (en)	2015-07-23
CA2928852A1 (en)	2015-05-07
MX377089B (es)	2025-03-07
HRP20191070T1 (hr)	2019-09-20
RS59000B1 (sr)	2019-08-30
EP3062811A2 (en)	2016-09-07
JP2016537416A (ja)	2016-12-01
ES2727532T3 (es)	2019-10-16
US10251938B2 (en)	2019-04-09
SMT201900295T1 (it)	2019-07-11
US20170136090A1 (en)	2017-05-18
AU2014342162B2 (en)	2020-01-02
US20190175699A1 (en)	2019-06-13
PL3062811T3 (pl)	2019-10-31
AU2014342162A1 (en)	2016-05-26
EP3062811B1 (en)	2019-04-03
KR20160099085A (ko)	2016-08-19
US9592271B2 (en)	2017-03-14
CN105873599A (zh)	2016-08-17
US9968653B2 (en)	2018-05-15
PT3062811T (pt)	2019-06-11
DK3062811T3 (da)	2019-05-13
US20180228870A1 (en)	2018-08-16
US10525106B2 (en)	2020-01-07
MX2016005446A (es)	2017-01-05
HUE044660T2 (hu)	2019-11-28
US20160045566A1 (en)	2016-02-18

Publication	Publication Date	Title
IL268987B (en)	2021-01-31	Glaucoma treatment system
PT3062811T (pt)	2019-06-11	Intervenções à base de angiopoietina para o tratamento da malária cerebral
GB201300928D0 (en)	2013-03-06	Apparatus
EP3050780A4 (en)	2016-11-02	STEERING APPARATUS
EP3018032A4 (en)	2016-06-15	STEERING DEVICE
GB201312991D0 (en)	2013-09-04	Process
PL3074449T3 (pl)	2017-11-30	Związki addycyjne poliamin
GB201307334D0 (en)	2013-05-29	Process
HUP1300280A2 (en)	2014-11-28	Equipment for increase arm-muscles
PL3072117T3 (pl)	2019-02-28	Sposób frakcjonowania materiałów lignocelulozowych
PL2976209T3 (pl)	2017-07-31	Urządzenie do tłoczenia folii
GB2520163B (en)	2018-01-10	Fall prevention apparatus
GB201312517D0 (en)	2013-08-28	Apparatus
GB201307327D0 (en)	2013-05-29	Process
GB201302441D0 (en)	2013-03-27	Process
GB201307951D0 (en)	2013-06-12	Process
GB201300073D0 (en)	2013-02-20	Process
GB201311738D0 (en)	2013-08-14	Apparatus
GB201310529D0 (en)	2013-07-24	Traysealing apparatus
GB201418099D0 (en)	2014-11-26	Process
GB201314674D0 (en)	2013-10-02	Brake apparatus
GB201306686D0 (en)	2013-05-29	Fall prevention apparatus
GB201304447D0 (en)	2013-04-24	Fall prevention apparatus
GB201419631D0 (en)	2014-12-17	Biomarkers for traumatic brain injury
ZA201306505B (en)	2014-05-28	Safety apparatus